- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02855736
Positive Psychology in Suicidal Patients (POPS)
Effectiveness of Positive Psychology in Suicidal Patients: A Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study design: monocentric randomized controlled study
Methods:
206 inpatients (Department of Emergency Psychiatry and Post Acute Care), between 18 and 65 years-old, having attempted suicide before hospitalisation or having current active suicidal ideation at the time of the psychiatric hospitalisation. Patients suffering from schizophrenia are excluded.
Randomization into two groups: Positive Psychology (i.e., gratitude journal) (n = 103) or Control Task (i.e., food journal) (n = 103), daily exercises during 7 days (in add-on from usual treatment).
Clinical assessment: 1) at baseline (the day before the intervention beginning) (V0); 2) short daily self-assessments (immediately before and after the exercise); 3) the day following the last day of the intervention (V1).
- V0 : socio-demographic data, treatments, psychopathology, suicidal ideation,depressive and anxious symptomatology, psychological pain, optimism, hopelessness.
- Daily self-assessments: psychological pain, optimism, hopelessness
- V1 : treatments suicidal ideation,depressive and anxious symptomatology, psychological pain, optimism, hopelessness, intervention satisfaction.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Hérault
-
Montpellier, Hérault, France
- Recruiting
-
Contact:
- Catherine Genty, MD
- Phone Number: +33 4 67 61 45 75
- Email: c-genty@chu-montpellier.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion criteria:
- Being hospitalized for suicidal thoughts or suicide attempt (from less than a week)
- Having signed informed consent
- Be fluent in French
- Able to understand nature, aims and methodology of the study
Exclusion criteria:
- Lifetime history of schizophrenia according to the Diagnostic and Statistical Manual of Mental Disorders - V (DSM-V) criteria
- Current eating disorder according to DSM-V criteria
- Patient on protective measures (guardianship or trusteeship)
- Deprived of liberty subject (judicial or administrative decision)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention group
Positive Psychology (gratitude journal)
|
Gratitude Journal (Emmons and Stern, 2013) Every evening, patients have to write down the things they feel grateful about. |
|
Placebo Comparator: Control group
Alimentary list
|
Food journal (i.e. alimentary list): Patients have to write down the list of foods eaten during the day. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Psychological pain reduction using a likert scale
Time Frame: At the inclusion and day 8 (the day after the end of the intervention)
|
Psychological pain reduction, in gratitude vs control group, between the beginning and the end of the intervention, using a likert scale.
|
At the inclusion and day 8 (the day after the end of the intervention)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Psychological pain reduction using a likert scale
Time Frame: At day 1, 2, 3, 4, 5, 6, 7
|
Psychological pain reduction, in gratitude vs control group, the beginning and the end of each exercise, using a likert scale.
|
At day 1, 2, 3, 4, 5, 6, 7
|
|
intensity of suicidal ideation
Time Frame: At the inclusion and day 8 (the day after the end of the intervention)
|
Reduction of suicidal ideation intensity, in gratitude vs control group between the beginning and the end of the intervention using a Likert Scale and the Scale for Suicidal Ideation (SSI).
|
At the inclusion and day 8 (the day after the end of the intervention)
|
|
Intensity of hopelessness
Time Frame: At the inclusion and day 8 (the day after the end of the intervention)
|
Reduction of hopelessness, in gratitude vs control group between the beginning and the end of the intervention, using a Likert Scale and the Beck Hopelessness Scale (BHS).
|
At the inclusion and day 8 (the day after the end of the intervention)
|
|
Intensity of optimism
Time Frame: At the inclusion and day 8 (the day after the end of the intervention)
|
Reduction of hopelessness, in gratitude vs control group between the beginning and the end of the intervention, using a Likert Scale and the Life Orientation Test-Revised (LOT-R).
|
At the inclusion and day 8 (the day after the end of the intervention)
|
|
Intensity of depressive symptoms using the Beck Depression Inventory (BDI)
Time Frame: Day 8 (the day after the end of the intervention)
|
Reduction of depressive symptoms between the beginning and the end of the intervention, using the Beck Depression Inventory (BDI)
|
Day 8 (the day after the end of the intervention)
|
|
Intensity of anxious symptoms using the State Anxiety Inventory- State (SAI-State)
Time Frame: Day 8 (the day after the end of the intervention)
|
Reduction of anxious symptoms between the beginning and the end of the intervention, using the State Anxiety Inventory- State (SAI-State)
|
Day 8 (the day after the end of the intervention)
|
|
Perceived usefulness of the intervention using a likert scale
Time Frame: Day 8 (the day after the end of the intervention)
|
Evaluation of the perceived usefulness of each intervention, using a likert scale.
|
Day 8 (the day after the end of the intervention)
|
|
Intensity of suicidal ideation
Time Frame: At day 1, 2, 3,4 5, 6, 7
|
Reduction of suicidal ideation intensity, in gratitude vs control group between the beginning and the end of each exercise, using a Likert Scale.
|
At day 1, 2, 3,4 5, 6, 7
|
|
Intensity of hopelessness
Time Frame: At day 1, 2, 3, 4, 5, 6, 7
|
Reduction of hopelessness, in gratitude vs control group between the beginning and the end of each exercise, using a Likert Scale.
|
At day 1, 2, 3, 4, 5, 6, 7
|
|
Intensity of optimism
Time Frame: At day 1, 2, 3, 4, 5, 6, 7
|
Reduction of hopelessness, in gratitude vs control group between the beginning and the end of each exercise, using a Likert Scale.
|
At day 1, 2, 3, 4, 5, 6, 7
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- UF 9557
- 2015-A00358-41 (Other Identifier: FRANCE: Agence Nationale de Sécurité des Médicaments)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Suicidal Thoughts
-
Rhode Island HospitalNational Institute of Mental Health (NIMH)Enrolling by invitation
-
VA Office of Research and DevelopmentRecruitingSocial Isolation | Suicidal Thoughts and BehaviorsUnited States
-
Stanford UniversityNot yet recruitingSuicidal Thoughts and BehaviorsUnited States
-
University of California, San DiegoRecruitingSuicidal Thoughts and BehaviorsUnited States
-
Children's Hospital Medical Center, CincinnatiCompleted
-
University GhentCompleted
-
Mental Health Services in the Capital Region, DenmarkUniversity of AarhusCompleted
-
Massachusetts General HospitalCompletedSuicideUnited States
-
Western UniversityWestern University, Canada; Social Sciences and Humanities Research Council...Not yet recruitingYouth | Suicidal Thoughts | Sexual and Gender Minorities
-
University of PittsburghNational Institute of Mental Health (NIMH)RecruitingSocial Connectedness | Suicidal Thoughts and Behaviors | Responses to Social ThreatUnited States
Clinical Trials on Positive Psychology
-
Brigham and Women's HospitalCompletedMultiple SclerosisUnited States
-
Assuta Ashdod HospitalNot yet recruitingPain | Anxiety | Virtual Reality
-
Swiss Paraplegic Research, NottwilCompletedChronic Pain | Spinal Cord InjurySwitzerland
-
Massachusetts General HospitalCompletedType 2 DiabetesUnited States
-
Brigham and Women's HospitalMassachusetts General Hospital; Consortium of Multiple Sclerosis CentersCompletedMultiple SclerosisUnited States
-
The Hong Kong Polytechnic UniversityRecruitingAdolescent DevelopmentHong Kong
-
Brigham and Women's HospitalNational Cancer Institute (NCI)CompletedHematopoietic/Lymphoid Cancer | Hematologic Malignancy | Blood CancerUnited States
-
Brigham and Women's HospitalCompletedHematologic Malignancy | CaregiverUnited States
-
Massachusetts General HospitalNational Heart, Lung, and Blood Institute (NHLBI)CompletedAcute Coronary SyndromeUnited States
-
Massachusetts General HospitalCompletedSuicidal Ideation | Suicide AttemptUnited States